×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
26124351
2015
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
26124351
2015
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models.
25221644
2014
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models.
25221644
2014
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Molecular profiling of single circulating tumor cells with diagnostic intention.
25358515
2014
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Molecular profiling of single circulating tumor cells with diagnostic intention.
25358515
2014
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.
21638049
2012
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.
22302033
2012
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.
22302033
2012
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.
21638049
2012
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
20941507
2011
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation.
19617202
2011
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation.
19617202
2011
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
20941507
2011
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
21501481
2011
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
21501481
2011
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
19896266
2010
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
19896266
2010
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
20197467
2010
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
20197467
2010
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
20332317
2010
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
20332317
2010
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
19801490
2009
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Therapeutic
CTD_human
Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance.
19075277
2009
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
Mammary Neoplasms, Human
0.300
Biomarker
CTD_human
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.
19436038
2009